About the Simponi Aria® Dosing Tool
The Simponi Aria® (golimumab) Dosing Calculator is designed as a clinical support resource for healthcare professionals. It simplifies the process of determining the correct dose, vial requirements, and infusion parameters for adult patients based on their body weight, in accordance with the approved prescribing information for Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).
Understanding the Calculator Outputs
Upon entering the required patient information, the tool provides a comprehensive summary for infusion preparation and administration:
- Total Dose (mg): The precise dose of golimumab calculated based on the patient's weight at 2 mg/kg.
- Vials Required: The number of 50 mg/4 mL single-dose vials needed, rounded up to the nearest whole vial.
- Volume to Withdraw (mL): The total volume of Simponi Aria® to be drawn from the vials.
- Infusion Preparation: Instructions on the volume of 0.9% Sodium Chloride to remove from the 100 mL infusion bag to accommodate the drug volume.
- Infusion Rate: The recommended rate to administer the final admixture over 30 minutes.
- Dosing Schedule: If a treatment start date is provided, the tool projects the dates for the induction doses (Week 0, Week 4) and subsequent maintenance doses (every 8 weeks).
How to Use the Calculator
Follow these steps to generate a dosing calculation:
- Enter Patient Weight: Input the patient's current body weight. You can toggle between kilograms (kg) and pounds (lbs) for convenience; the calculation will automatically convert to kg.
- Select Indication: Choose the appropriate indication from the dropdown menu (RA, PsA, or AS).
- Set Treatment Start Date (Optional): Select a start date to generate a projected infusion schedule. If left blank, only the dose preparation details will be shown.
- Calculate: The results update in real-time as you enter the information. The "Calculate" button can also be used to refresh the output.
Dosing and Administration Overview
Simponi Aria® is administered as an intravenous infusion. The standard dosing for adults is 2 mg/kg given over 30 minutes, following an induction and maintenance schedule:
- Induction Phase: An initial dose at Week 0, followed by a second dose at Week 4.
- Maintenance Phase: Subsequent doses are administered every 8 weeks.
The medication must be diluted in a 100 mL infusion bag of 0.9% Sodium Chloride Injection, USP, prior to administration.
Switching Between Biologics
When transitioning a patient to Simponi Aria® from another biologic agent, healthcare providers should exercise clinical judgment. Consideration should be given to the half-life and mechanism of action of the previous medication to minimize the risk of overlapping side effects or a potential gap in therapeutic efficacy.
Guidance for a Missed Dose
If a patient misses a scheduled maintenance infusion, the dose should be administered as soon as possible. The subsequent maintenance infusions should then be rescheduled to occur every 8 weeks from the date of this last infusion to maintain the correct interval.
Safety Alerts
Frequently Asked Questions (FAQ)
How is the total dose calculated?
The total dose is determined by the formula: Patient Weight (in kg) × 2 mg/kg. The result is rounded to the nearest whole milligram.
How does the calculator determine the number of vials?
Each vial of Simponi Aria® contains 50 mg of golimumab. The calculator divides the total required dose by 50 and rounds the result up to the next whole number to ensure enough medication is available for preparation.
Why must saline be removed from the infusion bag?
To ensure the final concentration and total volume are correct for a standard 30-minute infusion, a volume of saline equal to the drug volume to be added is first removed from the 100 mL bag. This maintains a final infusion volume of 100 mL.
Can this calculator be used for pediatric patients?
No. This tool is intended for calculating adult doses only and should not be used for pediatric populations with polyarticular juvenile idiopathic arthritis (pJIA) or juvenile psoriatic arthritis (jPsA).
Does the calculator account for patients with renal or hepatic impairment?
No. The use of Simponi Aria® in patients with renal or hepatic impairment has not been studied. Dosing adjustments are not specified in the Prescribing Information, and clinical judgment is required.
How is the projected infusion schedule determined?
The schedule follows the standard regimen: the first induction dose is on the selected start date (Week 0), the second is 4 weeks later, and all subsequent maintenance doses are at 8-week intervals thereafter.
What is the concentration of Simponi Aria® used in the calculation?
The calculation is based on the standard concentration of Simponi Aria®, which is 50 mg in 4 mL, equivalent to 12.5 mg/mL.
Is this tool a substitute for the official Prescribing Information?
No. This tool is for informational and educational purposes only. It is not a substitute for clinical judgment or the official U.S. Prescribing Information, which is the definitive source for all prescribing and administration guidance.
References
- 1. SIMPONI ARIA® (golimumab) Prescribing Information. Janssen Biotech, Inc. Horsham, PA.
- 2. SimponiAriaHCP.com. Official Healthcare Professional Website. Janssen Global.
- 3. Simponi (golimumab) European public assessment report (EPAR). European Medicines Agency.
- 4. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021;73(7):1108-1123.
